富士达(835640) - 2023 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 2.07% to ¥118,271,532.48 for the first nine months of 2023[12] - Operating income for the first nine months of 2023 was ¥663,064,339.01, a 5.14% increase year-on-year[12] - Net profit for the first nine months of 2023 was ¥124,638,556.66, a slight increase from ¥122,761,239.72 in the previous year, representing a growth of 1.5%[46] - The net profit attributable to the parent company for the period was CNY 115,834,712.95[22] - The total comprehensive income amounted to CNY 124,697,095.35, compared to CNY 122,968,234.52 in the previous year, reflecting an increase of approximately 1.4%[47] - The company's operating revenue for the first nine months of 2023 reached CNY 654,526,228.45, up from CNY 630,002,714.44 in the same period last year, representing a growth of about 3.9%[48] - The net profit for the first nine months of 2023 was CNY 117,523,895.53, slightly down from CNY 121,435,867.85, indicating a decrease of approximately 3.2%[48] Assets and Liabilities - Total assets decreased by 5.73% to ¥1,314,249,928.37 compared to the end of last year[11] - The company's net assets attributable to shareholders increased by 10.02% to ¥828,656,960.47 compared to the end of last year[11] - Total current assets increased from ¥904,991,907.98 in September 2022 to ¥1,019,726,484.23 in December 2023, representing a growth of approximately 12.6%[38] - Total liabilities rose from ¥458,848,149.55 in September 2022 to ¥613,883,575.28 in December 2023, indicating an increase of approximately 33.8%[40] - The total assets at the end of the reporting period amounted to CNY 1,393,940,968.31[22] - The company's total assets decreased to ¥1,281,338,905.03 from ¥1,343,833,909.56, a decline of approximately 4.6%[42] Cash Flow - Cash flow from operating activities improved significantly, with a net cash flow of -¥9,363,159.62, a 62.56% reduction in losses compared to the same period last year[12] - Net cash flow from operating activities improved by 62.56% to CNY -9,363,159.62, supported by refined management of accounts receivable and optimized sales assessment policies[17] - The net cash flow from operating activities was negative at CNY -9,363,159.62, an improvement from CNY -25,009,366.26 in the same period last year[51] - Cash and cash equivalents increased significantly from ¥79,970,730.06 in September 2022 to ¥244,036,723.79 in December 2023, marking an increase of approximately 205.5%[38] - Cash received from sales of goods and services was $469.66 million, compared to $359.82 million in the same period of 2022, reflecting a 30.6% increase[53] Borrowings and Financial Expenses - Short-term borrowings increased by 62.08% to ¥71,860,498.51, primarily to supplement working capital[15] - Long-term borrowings increased by 350.00% to CNY 45,000,000.00, primarily to meet daily operational needs[16] - Financial expenses rose by 92.83% to CNY 1,725,687.88, mainly due to a decrease in foreign exchange gains compared to the same period last year[16] - The company reported a decrease in financial liabilities, with short-term borrowings rising to ¥63,786,493.13 from ¥40,332,117.85, an increase of 58%[43] Inventory and Accounts Receivable - Inventory decreased by 32.30% to ¥111,519,374.17, reflecting improved inventory management[15] - The company reported a significant increase in accounts receivable by 59.90% to ¥589,917,914.52, mainly due to delayed payments in the defense sector[15] - Accounts receivable decreased from ¥589,917,914.52 in September 2022 to ¥368,933,576.39 in December 2023, a decline of about 37.5%[38] Shareholder Information - The total number of shares outstanding is 187,728,000, with 175,532,911 shares (93.50%) being freely tradable[24] - The largest shareholder, AVIC Optoelectronics Technology Co., Ltd., holds 87,551,776 shares, representing 46.64% of the total shares[25] - The company has 7,057 common shareholders as of the end of the reporting period[24] Research and Development - Research and development expenses for the first nine months of 2023 were ¥52,419,219.84, compared to ¥41,682,182.36 in the same period last year, marking a 25.8% increase[45] - Research and development expenses rose to CNY 55,850,892.07, compared to CNY 43,978,452.20 in the previous year, reflecting an increase of approximately 27%[48] Other Financial Metrics - The weighted average return on net assets based on net profit was 15.03%, down from 17.03% in the previous year[12] - Basic and diluted earnings per share increased to CNY 0.6300 from CNY 0.6172, marking a rise of about 2.3%[47] - The total operating profit decreased to CNY 124,569,083.29 from CNY 134,984,760.69, reflecting a decline of approximately 7.7%[48] - The company incurred a financial expense of CNY 1,475,161.27, compared to a financial income of CNY -12,551.49 in the previous year, indicating a significant shift in financial performance[48]